BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26

• Business

  Agios Pharmaceuticals Attracts Leading Cancer Metabolism Experts to Advisory Team

  November 24, 2008

   · 

  1 min read
• Drug Development

  Ariad Pharmaceuticals, Inc. to Present Preclinical Data on Multi-Targeted Kinase Inhibitor at 50th Ash Annual Meeting

  November 24, 2008

   · 

  1 min read
• Drug Development

  Cerus Corporation Initiates Phase I Clinical Trial for INTERCEPT Red Blood Cell System

  November 24, 2008

   · 

  1 min read
• Dr. Reddy’s Laboratories Ltd.’s Launches Authorized Generic Version of Imitrex(R) Tablets

  November 24, 2008

   · 

  1 min read
• Pharm Country

  First Percutaneous Liver and Kidney Lesions Treated With AngioDynamics’ IRE Technology at Australia’s The Alfred Hospital

  November 24, 2008

   · 

  1 min read
• Drug Development

  Schering-Plough Corporation Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinson’s Disease

  November 24, 2008

   · 

  5 min read
• BioMidwest

  GeneThera, Inc. Announces it is Set to Begin Commercial Testing for Johne’s Disease as Soon as January, 2009

  November 24, 2008

   · 

  6 min read
• Business

  National Comprehensive Cancer Network Receives $1.5 Million Grant to Research Targeted Therapy in Bladder Cancer

  November 24, 2008

   · 

  1 min read
• Business

  BioTime Announces Third Quarter 2008 Financial Results

  November 24, 2008

   · 

  1 min read
• Pharm Country

  OSI Pharmaceuticals, Inc. to Webcast its R&D Analyst Day on Thursday, December 4th

  November 24, 2008

   · 

  1 min read